MedPlus Health Services Limited has intimated the stock exchanges about a scheduled Board of Directors meeting under Regulation 29 read with Regulation 33 of SEBI LODR Regulations, 2015.
The Board Meeting is scheduled to be held on July 21, 2026, with the primary agenda to consider and approve the un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY2027).
Following the Board Meeting, the un-audited financial results will be submitted to both BSE Limited and National Stock Exchange of India Limited. The results will also be hosted on the company's website at www.medplusindia.com and published in newspapers in accordance with SEBI LODR Regulations, 2015.
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the trading window for Designated Persons of the Company (including their immediate relatives) has been closed from July 01, 2026 to July 23, 2026 (both days inclusive).
This disclosure follows a previous letter dated June 24, 2026, and will be available on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Limited (www.nseindia.com).
The document was signed by Gangadi Madhukar Reddy, Managing Director & CEO, with DIN: 00098097.